124 related articles for article (PubMed ID: 8618453)
1. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S
Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453
[TBL] [Abstract][Full Text] [Related]
2. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells.
Kitanaka A; Waki M; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
Biochem Biophys Res Commun; 1994 Jun; 201(3):1534-40. PubMed ID: 7517673
[TBL] [Abstract][Full Text] [Related]
3. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
4. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
[TBL] [Abstract][Full Text] [Related]
5. Involvement of phosphatidylinositol 3-kinase in the mediation of erythropoietin-induced activation of p70S6k.
Jaster R; Bittorf T; Brock J
Cell Signal; 1997 Feb; 9(2):175-9. PubMed ID: 9113417
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
8. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
9. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
10. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
[TBL] [Abstract][Full Text] [Related]
11. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells.
Tomiyama K; Nakata H; Sasa H; Arimura S; Nishio E; Watanabe Y
Biochem Biophys Res Commun; 1995 Jul; 212(1):263-9. PubMed ID: 7541986
[TBL] [Abstract][Full Text] [Related]
12. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation.
Ai Z; Misra S; Susa M; Varticovski L; Cohen CM
Exp Cell Res; 1995 Aug; 219(2):454-60. PubMed ID: 7641797
[TBL] [Abstract][Full Text] [Related]
14. Role of ERK activation in growth and erythroid differentiation of K562 cells.
Woessmann W; Mivechi NF
Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
[TBL] [Abstract][Full Text] [Related]
15. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells.
Missiroli S; Etro D; Buontempo F; Ye K; Capitani S; Neri LM
Int J Biochem Cell Biol; 2009 Mar; 41(3):570-7. PubMed ID: 18694847
[TBL] [Abstract][Full Text] [Related]
18. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2.
Tsushima H; Urata Y; Miyazaki Y; Fuchigami K; Kuriyama K; Kondo T; Tomonaga M
Cell Growth Differ; 1997 Dec; 8(12):1317-28. PubMed ID: 9419420
[TBL] [Abstract][Full Text] [Related]
19. c-FLIP is involved in erythropoietin-mediated protection of erythroid-differentiated cells from TNF-alpha-induced apoptosis.
Vittori D; Vota D; Callero M; Chamorro ME; Nesse A
Cell Biol Int; 2010 May; 34(6):621-30. PubMed ID: 20218968
[TBL] [Abstract][Full Text] [Related]
20. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
